Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 122.84 | 115.38 | -3.82 | 40.04 |
Depreciation/ Depletion | 2.61 | 6.06 | 9.65 | 12.16 |
Non- Cash Items | -59.36 | -54.98 | -15.29 | -17.14 |
Changesin Working Capital | 47.31 | -21.66 | 48.13 | -104.27 |
Cashfrom Operating Activities | 113.40 | 44.80 | 38.67 | -69.21 |
Capital Expenditures | 0.00 | -0.31 | -0.50 | -0.09 |
Other Investing Cash Flow Items Total | 33.13 | -152.94 | 87.54 | 95.25 |
Cashfrom Investing Activities | 33.13 | -153.25 | 87.04 | 95.16 |
Financing Cash Flow Items | -0.01 | -0.05 | -0.04 | -6.54 |
Total Cash Dividends Paid | -117.28 | -24.69 | -24.69 | -24.69 |
Issuance( Retirement)of Debt Net | -3.70 | -5.74 | -10.90 | -5.57 |
Cashfrom Financing Activities | -120.99 | -30.48 | -35.63 | -36.80 |
Net Changein Cash | 25.54 | -138.93 | 90.08 | -10.85 |
Cash Interest Paid | 0.01 | 0.05 | 0.04 | 6.54 |
Cash Taxes Paid | -38.27 | -2.34 | 18.59 | 35.19 |
Novartis India Dividend Novartis India Bonus Novartis India News Novartis India AGM Novartis India Rights Novartis India Splits Novartis India Board Meetings Novartis India Key Metrics Novartis India Shareholdings Novartis India Profit Loss Novartis India Balance Sheet Novartis India Q1 Results Novartis India Q2 Results Novartis India Q3 Results Novartis India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks